The development of PARP as a successful target for cancer therapy-Reference-Cited by-同舟云学术

The development of PARP as a successful target for cancer therapy

Published:2017-12-26 Issue:2 Volume:18 Page:161-175
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Ferrara Roberto¹²³,Simionato Francesca¹²^ORCID,Ciccarese Chiara¹²,Grego Elisabetta¹²,Cingarlini Sara²,Iacovelli Roberto²,Bria Emilio¹²,Tortora Giampaolo¹²,Melisi Davide¹²^ORCID

Affiliation:

1. Section of Oncology, Department of Medicine, Università degli Studi di Verona, Verona, Italy

2. Medical Oncology Unit, Azienda Ospedaliera Universitaria Integrata, Verona, Italy

3. Medical Oncology Department, Gustave Roussy, Villejuif, France

Funder

Associazione Italiana per la Ricerca sul Cancro

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737140.2018.1419870

Reference155 articles.

1. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis

2. Genome maintenance mechanisms for preventing cancer

3. Homologous recombination and non-homologous end-joining pathways of DNA double-strand break repair have overlapping roles in the maintenance of chromosomal integrity in vertebrate cells

4. Classical and Alternative End-Joining Pathways for Repair of Lymphocyte-Specific and General DNA Double-Strand Breaks

5. The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Novel Inhibitor of Poly(ADP-Ribose) Polymerase-1 Inhibits Proliferation of a BRCA-Deficient Breast Cancer Cell Line via the DNA Damage–Activated cGAS–STING Pathway;Chemical Research in Toxicology;2024-03-27

2. Major adverse cardiac events and cardiovascular toxicity with PARP inhibitors-based therapy for solid tumors: a systematic review and safety meta-analysis;ESMO Open;2023-04

3. In Silico Investigation of the Molecular Mechanism of PARP1 Inhibition for the Treatment of BRCA-Deficient Cancers;Molecules;2023-02-15

4. Replication Stress: A Review of Novel Targets to Enhance Radiosensitivity-From Bench to Clinic;Frontiers in Oncology;2022-07-08

5. Target based chemotherapeutic advancement of ruthenium complexes;Coordination Chemistry Reviews;2021-12